These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22539083)

  • 1. High-priority drug-drug interactions for use in electronic health records.
    Phansalkar S; Desai AA; Bell D; Yoshida E; Doole J; Czochanski M; Middleton B; Bates DW
    J Am Med Inform Assoc; 2012; 19(5):735-43. PubMed ID: 22539083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Criteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health records.
    Phansalkar S; Desai A; Choksi A; Yoshida E; Doole J; Czochanski M; Tucker AD; Middleton B; Bell D; Bates DW
    BMC Med Inform Decis Mak; 2013 Jun; 13(1):65. PubMed ID: 23763856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records.
    Phansalkar S; van der Sijs H; Tucker AD; Desai AA; Bell DS; Teich JM; Middleton B; Bates DW
    J Am Med Inform Assoc; 2013 May; 20(3):489-93. PubMed ID: 23011124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-priority and low-priority drug-drug interactions in different international electronic health record systems: A comparative study.
    Cornu P; Phansalkar S; Seger DL; Cho I; Pontefract S; Robertson A; Bates DW; Slight SP
    Int J Med Inform; 2018 Mar; 111():165-171. PubMed ID: 29425628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse drug events.
    Edrees H; Amato MG; Wong A; Seger DL; Bates DW
    J Am Med Inform Assoc; 2020 Jun; 27(6):893-900. PubMed ID: 32337561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in high-priority drug-drug interaction alerts across institutions and electronic health records.
    McEvoy DS; Sittig DF; Hickman TT; Aaron S; Ai A; Amato M; Bauer DW; Fraser GM; Harper J; Kennemer A; Krall MA; Lehmann CU; Malhotra S; Murphy DR; O'Kelley B; Samal L; Schreiber R; Singh H; Thomas EJ; Vartian CV; Westmorland J; McCoy AB; Wright A
    J Am Med Inform Assoc; 2017 Mar; 24(2):331-338. PubMed ID: 27570216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of medication alerts in electronic health records for compliance with human factors principles.
    Phansalkar S; Zachariah M; Seidling HM; Mendes C; Volk L; Bates DW
    J Am Med Inform Assoc; 2014 Oct; 21(e2):e332-40. PubMed ID: 24780721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three commercial knowledge bases for detection of drug-drug interactions in clinical decision support.
    Fung KW; Kapusnik-Uner J; Cunningham J; Higby-Baker S; Bodenreider O
    J Am Med Inform Assoc; 2017 Jul; 24(4):806-812. PubMed ID: 28339701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for selecting drug-drug interactions for clinical decision support.
    Tilson H; Hines LE; McEvoy G; Weinstein DM; Hansten PD; Matuszewski K; le Comte M; Higby-Baker S; Hanlon JT; Pezzullo L; Vieson K; Helwig AL; Huang SM; Perre A; Bates DW; Poikonen J; Wittie MA; Grizzle AJ; Brown M; Malone DC
    Am J Health Syst Pharm; 2016 Apr; 73(8):576-85. PubMed ID: 27045070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core drug-drug interaction alerts for inclusion in pediatric electronic health records with computerized prescriber order entry.
    Harper MB; Longhurst CA; McGuire TL; Tarrago R; Desai BR; Patterson A;
    J Patient Saf; 2014 Mar; 10(1):59-63. PubMed ID: 24522227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical reasoning in the context of active decision support during medication prescribing.
    Horsky J; Aarts J; Verheul L; Seger DL; van der Sijs H; Bates DW
    Int J Med Inform; 2017 Jan; 97():1-11. PubMed ID: 27919368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electronic drug interaction alerts in ambulatory care: the value and acceptance of high-value alerts in US medical practices as assessed by an expert clinical panel.
    Weingart SN; Seger AC; Feola N; Heffernan J; Schiff G; Isaac T
    Drug Saf; 2011 Jul; 34(7):587-93. PubMed ID: 21663334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug-drug interaction alerts.
    Baysari MT; Zheng WY; Li L; Westbrook J; Day RO; Hilmer S; Van Dort BA; Hargreaves A; Kennedy P; Monaghan C; Doherty P; Draheim M; Nair L; Samson R
    BMJ Open; 2019 Aug; 9(8):e026034. PubMed ID: 31427312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical drug-drug interactions for use in electronic health records systems with computerized physician order entry: review of leading approaches.
    Classen DC; Phansalkar S; Bates DW
    J Patient Saf; 2011 Jun; 7(2):61-5. PubMed ID: 21577077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Shared Electronic Health Record Systems on Drug-Drug Interaction and Duplication Warning Detection.
    Rinner C; Grossmann W; Sauter SK; Wolzt M; Gall W
    Biomed Res Int; 2015; 2015():380497. PubMed ID: 26682218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful deployment of drug-disease interaction clinical decision support across multiple Kaiser Permanente regions.
    Bubp JL; Park MA; Kapusnik-Uner J; Dang T; Matuszewski K; Ly D; Chiang K; Shia S; Hoberman B
    J Am Med Inform Assoc; 2019 Oct; 26(10):905-910. PubMed ID: 30986823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Overridden Medication-related Clinical Decision Support in the Intensive Care Unit between a Commercial System and a Legacy System.
    Wong A; Wright A; Seger DL; Amato MG; Fiskio JM; Bates D
    Appl Clin Inform; 2017 Aug; 8(3):866-879. PubMed ID: 28832067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of drug-drug interaction alert rules in a pediatric hospital's electronic health record system using a visual analytics dashboard.
    Simpao AF; Ahumada LM; Desai BR; Bonafide CP; Gálvez JA; Rehman MA; Jawad AF; Palma KL; Shelov ED
    J Am Med Inform Assoc; 2015 Mar; 22(2):361-9. PubMed ID: 25318641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structured override reasons for drug-drug interaction alerts in electronic health records.
    Wright A; McEvoy DS; Aaron S; McCoy AB; Amato MG; Kim H; Ai A; Cimino JJ; Desai BR; El-Kareh R; Galanter W; Longhurst CA; Malhotra S; Radecki RP; Samal L; Schreiber R; Shelov E; Sirajuddin AM; Sittig DF
    J Am Med Inform Assoc; 2019 Oct; 26(10):934-942. PubMed ID: 31329891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-drug interaction checking assisted by clinical decision support: a return on investment analysis.
    Helmons PJ; Suijkerbuijk BO; Nannan Panday PV; Kosterink JG
    J Am Med Inform Assoc; 2015 Jul; 22(4):764-72. PubMed ID: 25670751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.